Shopping Cart
Remove All
Your shopping cart is currently empty
PT3 is a selective inhibitor of HDAC3 with an IC50 value of 0.25 μM. It demonstrates good brain penetration and bioavailability when administered orally. PT3 is applicable for research in Alzheimer's disease.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | PT3 is a selective inhibitor of HDAC3 with an IC50 value of 0.25 μM. It demonstrates good brain penetration and bioavailability when administered orally. PT3 is applicable for research in Alzheimer's disease. |
| Targets&IC50 | HDAC2:2.08 μM |
| Molecular Weight | 319.36 |
| Formula | C18H17N5O |
| Cas No. | 2710273-81-5 |
| Smiles | O=C(NC=1C=CC=CC1N)C=2N=CC(=NC2)NCC=3C=CC=CC3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.